Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma

Figure 6

Expression of immune checkpoints between H-TIIC and L-TIIC subtypes in (a) TARGET cohort and (b) GSE21257 cohort.

(a)

(b)